Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Campath trial for T-PLL yields promising results

Oct. 2, 2001

Pharmexa cleared to begin phase I/II breast cancer trial in the U.K.

Sep. 28, 2001

New DNA vaccine provides both tumor-specific immunity and antiangiogenesis

Sep. 25, 2001

Allovectin-7 phase III registration trial in metastatic melanoma now fully enrolled

Sep. 20, 2001

Rituximab now available in Japan

Sep. 14, 2001

NeoPharm seeks orphan drug status for IL-13-PE38

Sep. 14, 2001

Provenge advances towards 2002 BLA submission

Sep. 13, 2001

AltaRex completes primary analysis of OvaRex clinical trial

Sep. 7, 2001

Positive preliminary phase II data reported for Stressgen's HspE7

Sep. 7, 2001

Major European launch announced for new CLL therapy

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...